Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
22.22
+0.74 (3.45%)
At close: Aug 13, 2025, 4:00 PM
21.95
-0.27 (-1.22%)
After-hours: Aug 13, 2025, 7:47 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $570.80 million as of August 13, 2025. Its market cap has increased by 23.99% in one year.
Market Cap
570.80M
Enterprise Value
332.48M
1-Year Change
23.99%
Ranking
Category
Stock Price
$22.22
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $570.80M, an increase of 157.50%. That is a compound annual growth rate of 68.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 551.79M | 6.11% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |